Healthcare -
Biotechnology - NASDAQ - US
$ 3.53
-0.843 %
$ 32.6 M
Market Cap
-0.56
P/E
SABS - CAPITAL EXPENDITURES
Capital Expenditures SABS - SAB Biotherapeutics, Inc.
-197 K
LAST VALUE
86.58%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR